A.T.S. Pharmaceuticals, a Division of Auriga Laboratories, Adds to Its Xyralid(TM) Franchise with the Introduction of Xyralid(TM) Cream.
Business Wire (September 06, 2007)
Permanent Link:
http://vlex.com/vid/auriga-xyralid-introduction-56859949
Id. vLex: VLEX-56859949
Acceda a este documento
y pruebe vLex GRATIS durante 3 días
Business
Business, general
Industrial chemicals
Pharmaceutical industry
Franchises
Glucocorticoids
Pramoxine
A.T.S. Pharmaceuticals, a Division of Auriga Laboratories, Adds to Its Xyralid(TM) Franchise with the Introduction of Xyralid(TM) Cream.
LOS ANGELES -- Auriga Laboratories, Inc. (OTCBB:ARGA), a specialty pharmaceutical company with products for the treatment of acute respiratory diseases, dermatological conditions, and xerostomia, announced today the launch of Xyralid[TM] Cream (lidocaine HCl 3%/hydrocortisone acetate 1%), a conveni...
Try vLex for FREE for 3 days
Access legal information from United States including:
- Constitutions
- Forms and Contracts
- Legal Books and Journals
- Case Law
- News and Business
- Regulations
- U.S. Code
Try vLex without any commitment for 3 days and see why you need it.
3
days of Free Access
If you are already a vLex customer, Access Here
